Baird Says Itron (ITRI) is Ready for Long-Term Growth - Raises PT to $47
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Baird Says Itron (ITRI) is Ready for Long-Term Growth - Raises PT to $47
February 18, 2016 9:47 AM EST
Wedbush analyst, David Rose, thinks that Itron (NASDAQ: ITRI) is in the early stages of a turnaround, based on improving margins and an impressive bookings figure. There is still execution risk but the elements are in place with Q4 results providing good evidence... More
February 17, 2016 4:10 PM EST
Itron (NASDAQ: ITRI) reported Q4 EPS of $0.76, $0.02 better than the analyst estimate of $0.74. Revenue for the quarter came in at $490.4 million versus the consensus estimate of $486.56 million.
GUIDANCE:
Itron sees FY2016 EPS of $1.95-$2.25, versus the consensus of $2.13. Itron sees... More
February 16, 2016 3:29 PM EST
The Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
PPI - Street sees (0.2%)Core PPI - Street sees 0.0%Housing Starts - Street sees 1.171MBuilding Permits - Street sees 1.200M
9:15am EST
Industrial Production - Street sees 0.3%Capacity Utilization - Street sees 76.6%
Earnings:
AMAG Pharma (Nasdaq: AMAG) - consensus EPS $1.16
Albany Molecular Research (Nasdaq: AMRI) - consensus EPS $0.36... More
